Functional role of IL-22 in psoriatic arthritis

Arthritis Research and Therapy

Volumn 14, Issue 2, 2012, Pages

  Mitra, Anupam ^a   Raychaudhuri, Smriti K ^b   Raychaudhuri, Siba P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; CYTOKINE RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR ALPHA1; INTERLEUKIN 22 RECEPTOR ANTIBODY; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 22; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ARTICLE; BLOOD; CD3+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SELECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST LIKE SYNOVIOCYTE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; OSTEOARTHRITIS; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE; WESTERN BLOTTING; CELL CULTURE; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INTERLEUKINS; OSTEOARTHRITIS; SYNOVIAL FLUID;

EID: 84858014222     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3781     Document Type: Article

References (41)

1. Wright V, Moll JMH. Psoriatic arthritis. Seronegative Polyarthritis 1976, 169-223. Amsterdam: North Holland Publishing Co, Wright V, Moll JMH.
2. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005, 64:ii14-17. 10.1136/ard.2004.032482, 1766874, 15708927.
3. Rahman P, Elder JT. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005, 64:ii37-39. 10.1136/ard.2004.030775, 1766868, 15708933.
4. Gladman DD. Psoriatic arthritis. Dermatol Ther 2004, 17:350-363. 10.1111/j.1396-0296.2004.04038.x, 15379770.
5. Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O. Reduced synovial membrane macrophage numbers, ELAM1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 1993, 36:893-900. 10.1002/art.1780360705, 7686370.
6. Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ. Patterns of cytokine production in psoriatic synovium. J Rheumatol 1998, 25:1544-1552.
7. Raychaudhuri SP, Raychaudhuri SK, Genovese MC. IL-17 receptor and its functional significance in psoriatic arthritis. Mol Cell Biochem 2012, 359:419-429. 10.1007/s11010-011-1036-6, 21894442.
8. Veale DJ, Ritchlin C, FitzGerald O. Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005, 64:ii26-29. 10.1136/ard.2004.031740, 1766860, 15708930.
9. Espinoza LR, Espinoza CG, Cuéllar ML, Scopelitis E, Silveira LH, Grotendorst GR. Fibroblast function in psoriatic arthritis. II: increased expression of PDGF receptors and increased production of GF and cytokines. J Rheumatol 1994, 21:1507-1511.
10. van Kuijk AW, Reinders-Blankert P, Smeets TJ, Dijkmans BA, Tak PP. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 2006, 65:1551-1557. 10.1136/ard.2005.050963, 1798447, 16728461.
11. Gitter BD, Labus JM, Lees SL, Scheetz ME. Characteristics of human synovial fibroblast activation by IL-1β and TNF-α. Immunology 1989, 66:196-200. 1385086, 2784408.
12. Yokota K, Miyazaki T, Hirano M, Akiyama Y, Mimura T. Simvastatin inhibits production of interleukin 6 (IL-6) and IL-8 and cell proliferation induced by tumor necrosis factor-alpha in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Rheumatol 2006, 33:463-471.
13. Choy EH, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001, 344:907-9 16. 10.1056/NEJM200103223441207, 11259725.
14. Ritchlin CT. Therapeutic considerations in spondyloarthritis patients who fail tumour necrosis factor antagonists. Best Pract Res Clin Rheumatol 2010, 24:683-692. 10.1016/j.berh.2010.06.002, 21035088.
15. Mease P. TNF alpha therapy in psoriatic arthritis and psoriasis. Ann Rheum Dis 2004, 63:755-758. 10.1136/ard.2004.020719, 1755077, 15194567.
16. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9. J Immunol 2000, 164:1814-1819.
17. Dumoutier L, Van Roost E, Colau D, Renauld JC. Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocytestimulating factor. Proc Natl Acad Sci USA 2000, 97:10144-10149. 27764, 10954742.
18. Wolk K, Witte E, Wallace E, Döcke WD, Kunz S, Asadullah K, Volk HD, Sterry W, Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006, 36:1309-1323. 10.1002/eji.200535503, 16619290.
19. Boniface K, Bernard F-X, Garcia M, Gurney AL, Lecron J-C, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005, 174:3695-3702.
20. Ikeuchi H, Kuroiwa T, Hiramatsu N, Kaneko Y, Hiromura K, Ueki K, Nojima Y. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum 2005, 52:1037-1046. 10.1002/art.20965, 15818686.
21. Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. Int Immunol 2011, 23:159-163. 10.1093/intimm/dxr001, 21393631.
22. Kotenko SV, Langer JA. Full house: 12 receptors for 27 cytokines. Int Immunopharmacol 2004, 4:593-608. 10.1016/j.intimp.2004.01.003, 15120645.
23. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 2004, 22:929-979. 10.1146/annurev.immunol.22.012703.104622, 15032600.
24. Renauld JC. Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 2003, 3:667-676. 10.1038/nri1153, 12974481.
25. Ren J, Feng Z, Lv Z, Chen X, Li J. Natural killer-22 cells in the synovial fluid of patients with rheumatoid arthritis are an innate source of interleukin 22 and tumor necrosis factor-α. J Rheumatol 2011, 38:2112-2118. 10.3899/jrheum.101377, 21765110.
26. Kotenko SV, Izotova LS, Mirochnitchenko OV, Esterova E, Dickensheets H, Donnelly RP, Pestka S. Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 2001, 276:2725-2732. 10.1074/jbc.M007837200, 11035029.
27. Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254. 10.1016/j.immuni.2004.07.007, 15308104.
28. Meephansan J, Ruchusatsawat K, Sindhupak W, Thorner PS, Wongpiyabovorn J. Effect of methotrexate on serum levels of IL-22 in patients with psoriasis. Eur J Dermatol 2011, 21:501-504.
29. Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld JC, Matthys P. Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum 2009, 60:390-395. 10.1002/art.24220, 19180498.
30. Fiocco U, Sfriso P, Oliviero F, Roux-Lombard P, Scagliori E, Cozzi L, Lunardi F, Calabrese F, Vezzù M, Dainese S, Molena B, Scanu A, Nardacchione R, Rubaltelli L, Dayer JM, Punzi L. Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. Arthritis Res Ther 2010, 12:R148. 10.1186/ar3090, 2945042, 20642840.
31. Wright V, Moll JM. Psoriatic arthritis. Bull Rheum Dis 1971, 21:627-632.
32. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, . CASPAR Study Group Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006, 54:2665-2673. 10.1002/art.21972, 16871531, CASPAR Study Group.
33. Raychaudhuri SP, Raychaudhuri SK. The regulatory role of nerve growth factor and its receptor system in fibroblast-like synovial cells. Scand J Rheumatol 2009, 38:207-215. 10.1080/03009740802448866, 19177265.
34. Raychaudhuri SK, Raychaudhuri SP. Functional significance of nerve growth factor and its receptor (TrkA) in inflammatory arthritis. Arthritis Res Ther 2010, 12:404. 10.1186/ar3030, 2911887, 20609261.
35. Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A. Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 2007, 9:461-417. 10.1007/s11926-007-0075-1, 2893221, 18177599.
36. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23 induced dermal inflammation and acanthosis. Nature 2007, 445:648-651. 10.1038/nature05505, 17187052.
37. Kim KW, Kim HR, Park JY, Park JS, Oh HJ, Woo YJ, Park MK, Cho ML, Lee SH. IL-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum 2011, doi: 10.1002/art.33446.
38. Caproni M, Antiga E, Melani L, Volpi W, Del Bianco E, Fabbri P. Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol 2009, 29:210-214. 10.1007/s10875-008-9233-0, 18763027.
39. Eyerich S, Wagener J, Wenzel V, Scarponi C, Pennino D, Albanesi C, Schaller M, Behrendt H, Ring J, Schmidt-Weber CB, Cavani A, Mempel M, Traidl-Hoffmann C, Eyerich K. IL-22 and TNF-α represent a key cytokine combination for epidermal integrity during infection with candida albicans. Eur J Immunol 2011, 41:1894-1901. 10.1002/eji.201041197, 21469124.
40. Guilloteau K, Paris I, Pedretti N, Boniface K, Juchaux F, Huguier V, Guillet G, Bernard FX, Lecron JC, Morel F. Skin Inflammation Induced by the Synergistic Action of IL-17A, IL-22, Oncostatin M, IL1{alpha}, and TNF-{alpha} Recapitulates Some Features of Psoriasis. J Immunol 2010,
41. Zhang Y, Dong J, He P, Li W, Zhang Q, Li N, Sun T. Genistein Inhibit Cytokines or Growth Factor-Induced Proliferation and Transformation Phenotype in Fibroblast-Like Synoviocytes of Rheumatoid Arthritis. Inflammation 2012, 35:377-387. 10.1007/s10753-011-9365-x, 21792602.